Drug Name Active Ingredient(s) Approval Date FDA-Approved Use on Approval Date Press Release Drug Trials Snapshot Vonjo pacritinib 2/28/2022 To treat intermediate or high-risk primary
Drug Name Active Ingredient(s) Approval Date FDA-Approved Use on Approval Date Press Release Drug Trials Snapshot Vabysmo faricimab-svoa 1/28/2022 To treat neovascular (wet) aged-related macular
